If you want to make someone wild about you, you have to start by getting into their head. Most of the time, people like someone who keeps them guessing, and makes them work for things ...

Donald Trump kicked off a new era of Western economic rivalry with Beijing when he took office in 2017. As he prepares for his second term, China’s dominance of global manufacturing is greater ...

Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab ... M.B.B.S., F.R.A.C.P., ...

[cemiplimab] was the first PD-1 inhibitor approved for certain patients with advanced cutaneous squamous cell carcinoma and has become a standard of care in this setting,” said Israel Lowy, MD, PhD, ...

The new group will be led by Jay Parikh, Facebook's former head of engineering whom Nadella added to Microsoft's senior leadership team in October. Microsoft is forming the group as it anticipates ...

Cemiplimab (Libtayo, Regeneron Pharmaceuticals ... FRACP, research lead of head and neck cancer and cutaneous squamous cell carcinoma in the department of medical oncology at Peter MacCallum ...

El Clasico is always a fiery affair. Lionel Messi (centre) and Sergio Ramos (right) go head-to-head. / AFLOSPORT/IMAGO Real Madrid versus Barcelona, best known as El Clásico, is the most famous ...

Sudden loud noises around sleep transitions may also occur as part of a condition called exploding head syndrome. What is exploding head syndrome? Learn about the most common symptoms, the causes and ...

These two sides have locked horns on 259 occasions throughout history, and it is Real Madrid that just about lead the head-to-head record, recording 105 wins to Barcelona's 102, while there have ...

This randomized trial evaluates the clinical activity and safety of BNT111 in combination with the anti-PD-1 antibody cemiplimab. The results from this trial underscore the potential of mRNA ...

The mRNA cancer vaccine market is poised for significant transformation, characterized by a growing pipeline of innovative therapies. While no mRNA cancer vaccines have received regulatory approval ...